Ozempic Might Be Much less Efficient for Emotional Eaters, Research Suggests

GLP-1 agonists—so-called “wonder medication” like Ozempic or Wegovy that assist people decrease blood sugar ranges and shed pounds, amongst different issues—yield important outcomes for some sufferers, however not all. Individuals’s motivations to overeat could play a task on this, in line with a brand new research.

To analyze why some individuals don’t profit from GLP-1 agonists as a lot as others, researchers noticed 92 individuals with kind 2 diabetes in Japan throughout their first yr of taking GLP-1 medication. Their results, printed as we speak in Frontiers in Medical Diabetes and Healthcare, recommend that individuals who overeat resulting from exterior causes—such because the sight or scent of scrumptious meals—had larger possibilities of responding effectively to the medication in the long run than individuals who overeat for emotional causes.

Who will profit most from GLP-1 medication?

“Pre-treatment evaluation of consuming conduct patterns could assist predict who will profit most from GLP-1 receptor agonist remedy,” Daisuke Yabe, senior creator of the research and a professor of diabetes, endocrinology, and diet at Kyoto College, mentioned in a Frontiers assertion. “GLP-1 receptor agonists are efficient for people who expertise weight acquire or elevated blood glucose ranges resulting from overeating triggered by exterior stimuli. Nonetheless, their effectiveness is much less anticipated in circumstances the place emotional consuming is the first trigger.”

The group revealed this by gathering knowledge on the individuals’ physique weight and composition, weight loss program, and knowledge equivalent to blood glucose, levels of cholesterol, and relationship with meals at the start of the therapy, three months after, and one yr after. They targeted on emotional consuming (consuming in response to detrimental feelings), exterior consuming (consuming as a result of the meals appears good), and restrained consuming (controlling one’s weight loss program to shed pounds). Whereas it might sound contradictory, extreme restrained consuming can really end in disordered consuming, in line with the researchers.

Over the yr, the individuals skilled a statistically important lack of physique weight and lowered levels of cholesterol and physique fats proportion with out altering skeletal muscle mass. Whereas blood glucose ranges ameliorated, the advance wasn’t statistically important. There have been, nevertheless, some variations relying on consuming behaviors. Three months after the beginning of the therapy, individuals reported extra restrained consuming and fewer exterior or emotional consuming. By the top of the yr, although, individuals had returned to their authentic restrained and emotional consuming habits.

“One attainable clarification is that emotional consuming is extra strongly influenced by psychological components which might not be straight addressed by GLP-1 receptor agonist remedy,” mentioned Takehiro Kato, second creator of the article and a researcher from Gifu College, “People with outstanding emotional consuming tendencies could require further behavioral or psychological assist.”

Exterior consuming lessened over the yr of therapy

Individuals reported decreased exterior consuming all through the whole yr, and people that claimed excessive ranges of exterior consuming at the start of the therapy noticed the best advantages in blood glucose ranges and weight reduction. Then again, the group didn’t establish any affiliation between emotional or restrained consuming scores at the start and drug advantages by the 12-month mark.

“Whereas our research suggests a possible affiliation between exterior consuming conduct and therapy response to GLP-1 receptor agonists, these findings stay preliminary,” defined Yabe. What’s extra, the group’s research was observational, and individuals self-reported info, which means the researchers revealed a possible affiliation, not a causation.

“Additional proof is critical earlier than they are often carried out in scientific follow. Ought to future large-scale or randomized managed trials validate this relationship, incorporating easy behavioral assessments may turn out to be a helpful part in optimizing therapy methods,” Yabe concluded.